葡萄糖激活的Janus伤口包裹用于增强感染和排泄性糖尿病伤口的管理
Liqin Tang1,2, Yingjie Zhang1,2, Huiru Zhang1,2
1Key Laboratory of Textile Science & Technology, Ministry of Education, Donghua University, Shanghai 201620, China.
ACS applied materials & interfaces
|December 18, 2024
概括
一种新的Janus伤口敷料结合了抗微生物纳米纤维和水性海绵来管理糖尿病伤口排泄物. 这种敷料有效杀死细菌,并在动物模型中加速伤口愈合.
科学领域:
- 生物医学工程 生物医学工程
- 材料科学 材料科学 材料科学
- 伤口愈合 伤口愈合
背景情况:
- 糖尿病伤口由于高葡萄糖,排泄物和感染而存在复杂的挑战.
- 现有的治疗方法很难有效地管理苛刻的伤口微环境.
研究的目的:
- 设计和准备一个Janus伤口包裹,用于管理糖尿病伤口排泄物和对抗感染.
- 为了利用级联反应增强抗微生物活性和伤口愈合.
主要方法:
- 用一种疏水性聚ε-烯酸乙烯 (PCL) 纳米纤维膜 (ENM) 层和一种疏水性3D海绵制造Janus连接剂.
- 在ENMs上集成具有过氧化酶类活性和葡萄糖氧化酶 (GOx) 的金属有机框架 (MOF).
- 通过GOx介导的葡萄糖消耗和pH调节来激活MOFs以产生基基 (•OH).
主要成果:
- GOx@PCL/MOF ENMs 显示了一种级联效应,产生反应性氧物种并表现出强大的抗菌特性.
- 在体内,雅努斯的敷料有效地减轻了耐甲素黄金葡萄球菌 (MRSA) 感染.
- 在体内研究表明,在动物模型中,到第3天的伤口愈合率为54%.
结论:
- 开发的Janus伤口带显示了治疗慢性糖尿病伤口的巨大潜力.
- 综合系统有效地解决了糖尿病伤口微环境中的关键挑战.
- 这种方法为加速伤口愈合和对抗感染提供了一个有希望的策略.
相关概念视频
01:06Oral Hypoglycemic Agents: Glinides
136
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
136
01:15Hypoglycemia and Glucagon
150
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
150
01:24Glucagon-like Receptor Agonists
297
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
297
01:24Inflammatory Response II: Inflammatory Exudate and Tissue Repair
4.7K
The immune system's inflammatory response destroys the invading pathogen, permitting the tissue to heal. The changes during the cellular and vascular stages allow exudate formation at the site of inflammation. The inflammatory exudate released from the wound has high protein content and a specific gravity above 1.020.
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
4.7K
01:19Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K